Daniel Abdun-Nabi, CEO at Emergent BioSolutions Inc. (EBS), bought 749 shares at $19.08 ($14K) on 2013-11-30, disclosed to the SEC on 2013-12-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| EBS | SELL | 2018-09-18 | $1.9M | — | Filing → |
| EBS | SELL | 2018-09-06 | $5.5M | — | Filing → |
| EBS | SELL | 2018-06-07 | $823K | — | Filing → |